Form 10-Q Kite Pharma, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Kite Pharma (KITE) Tops Q3 EPS by 51c
November 9, 2016 9:00 AM ESTKite Pharma (NASDAQ: KITE) reported Q3 EPS of ($1.10), $0.51 better than the analyst estimate of ($1.61). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $4.94 million.
For earnings history and earnings-related data on Kite Pharma (KITE) click here.
... More